Daniel Clay

Daniel Clay is a seasoned professional with extensive experience in the pharmaceutical industry, currently serving as Regional Business Director at Ascendis Pharma since March 2023. Previously, Daniel held multiple positions at Novo Nordisk from March 2007 to March 2023, including Associate Director of Commercial Communications, where leadership resulted in improved communication strategies for over 3,000 sales employees and earned recognition as the 2021 Winner of “Best in Benchmark” for field communications. Daniel also excelled as Associate Director of POA Planning, leading successful product launches, and achieved significant sales performance as a District Business Manager, earning several prominent awards. Early in Daniel's career, experience at Pfizer as a Professional Healthcare Representative helped develop a broad skill set in sales across multiple therapeutic areas. Daniel holds a BSBA in Management from the University of Missouri-Columbia, a Master of Health Administration from Webster University, and a PMP certification from Villanova University.